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SMALL BOWEL transplantation in humans. alone or in combination with other viscera. has been per-
formed frequently using FK506 immunosuppression. and a 
large number of studies in cellular rejection have accumu-
lated. However. the role of preformed lymphocytotoxic 
antibodies on small bowel transplantation is not yet de-
fined clearly. We reported previously that Lewis rats 
sensitized with multiple ACI skin grafts produced a high 
titer of anti-ACI lymphocytotoxic antibodies (IgG > > 
IgM) and hyperacutely rejected ACI heart and liver 
grafts.' We also showed that the survival of either kind of 
graft in sensitized recipients inversely correlated to the 
lymphocytotoxic antibody titer and the length oftime after 
the last skin grafting. When transplantation was delayed 
for 15 weeks or more after sensitization. heart and liver 
grafts were rejected in an antibody- and cell-mediated 
fashion. providing a clinically relevant animal model to 
study the role of preformed Iymphocytotoxic antibodies on 
transplantation. : 
In this study. using the same sensitization protocol. 
antibody-mediated small bowel allograft rejection was 
studied. Results were compared with those of other organ 
allografts in the same setting. 
MATERIALS AND METHODS 
Inbred Lewis (LEW. RTlI) and ACI (RTI") rats were used as 
recipients and donors. respectively. LEW rats were sensitized 
with four successive ACI tail skin grafts at 14-day intervals.' The 
surgical procedure of small bowel transplantation with caval 
drainage has been described before. l To characterize the his-
topathological changes of antibody-mediated rejection seen in 
small bowel grath. ACI intestine was transplanted into sensitized 
recipients either within 4 weeks In = 2) or more than 15 weeks 
(n = 3) after the last skin grafting. Serial specimens were taken 
from the graft intestine and lymphoid tissues and processed for 
histopathological analysis. 
In the following experiments. responses of small bowel graft to 
preformed antibodies were compared with those of other organ 
allografts. Sensitized recipients received either small bowel. 
heart. kidney. or liver graft from ACI rats more than 15 weeks 
after the last skin grafting. FKS06 was given at a dose of 1.0 
mglkgld for 7 days staning on the day of grafting to avoid acute 
cellular rejection. 
RESULTS 
Macroscopically. small bowel grafts transplanted into sen-
sitized animals within 4 weeks after the last skin graft 
became dark in color and developed congestion within a 
few minutes after normal revascularization. During the 
next 60 minutes. grafts became completely hemorrhagic. A 
notable histopathological change seen in these specimens 
was congestion of capillaries in the lamina propria. sub-
mucosa. and inside the Peyer's patches, with diffuse 
hemorrhage and edema. The number of congested capil-
laries and area of hemorrhage increased and extended to 
the villi with time. These changes in the grafts were 
macroscopically and histopathologically less severe when 
transplantation was delayed for more than 15 weeks. The 
inflammatory infiltrates of neutrophils and lymphocytes 
appeared between 18 and 26 hours after grafting in the 
latter specimen. 
When heart and kidney grafts were transplanted into 
sensitized recipients more than 15 weeks after skin grafting 
under FK506 treatment. median graft survivals were 4.5 
(n = 4) and 3 days (n = 4). respectively. These survival 
times were much shorter than those seen in unsensitized 
recipients both with and without immunosuppression. sug-
gesting that irreversible antibody-mediated damage oc-
curred to these grafts. When live(grafts. which have been 
known to be resistant to antibody-mediated damage, were 
transplanted, three of five animals had a prolonged sur-
vival of more than 80 days and two survived for more than 
100 days. After small bowel grafting in the same condition. 
three out of five animals died within 5 days: however. the 
other two survived for more than 100 days. 
DISCUSSION 
Although the development of acute cellular rejection fol-
lowing small bowel transplantation was demonstrated. 
antibody-mediated rejection in this transplantation is not 
clearly defined. Using a well-established animal model of 
antibody-mediated allograft rejection. humoral rejection of 
the small bowel graft was characterized in this study. 
Typical histopathological changes were capillary conges-
tion and hemorrhage seen in lamina propria. submucosa. 
and inside the lymphoid tissues of Peyer's patches and 
mesenteric lymph nodes. and later in the villi. Similar 
findings were observed in one patient who received cross-
match positive isolated small bowel graft. Postperfusion 
biopsy of this patient showed capillary congestion and 
hemorrhage. which lasted for 2 weeks after transplanta-
tion. 
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Delayed transplantation to primed animals (> 15 weeks) 
under FK506 treatment was performed because of the 
relevance to the grafting to presensitized patients. In spite 
of sufficient FK506 treatment. survival times of heart and 
kidney grafts in sensitized recipients were reduced when 
compared to those in unsensitized recipients. Damage to 
heart and kidney grafts caused by preformed antibodies 
may be irreversible. On the other hand. 60% of liver grafts 
and 40% of small bowel grafts showed extended survival of 
more than 80 days in the same setting. The small bowel 
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graft may be more resistant to antibody-mediated damage 
compared to hean and kidney grafts. 
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